載入...
Targeting Human C-Type Lectin-Like Molecule-1 (CLL1) with a Bispecific Antibody for Acute Myeloid Leukemia Immunotherapy
Acute myeloid leukemia (AML), the most common acute adult leukemia and the second most common pediatric leukemia, still has a poor prognosis. Human C-type lectin-like molecule-1 (CLL1) is a recently identified myeloid lineage restricted cell surface marker, which is overexpressed in over 90% of AML...
Na minha lista:
| 發表在: | Angew Chem Int Ed Engl |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4280064/ https://ncbi.nlm.nih.gov/pubmed/25056598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/anie.201405353 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|